Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001027121 | SCV001189627 | uncertain significance | Hereditary cancer-predisposing syndrome | 2018-06-18 | criteria provided, single submitter | clinical testing | The p.K269E variant (also known as c.805A>G), located in coding exon 6 of the STK11 gene, results from an A to G substitution at nucleotide position 805. The lysine at codon 269 is replaced by glutamic acid, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |